Oral presentation to highlight ATNM-400 antitumor activity across KRAS- and ALK-driven NSCLC models, building on earlier EGFR-mutant findings and supporting mutation-agnostic developmentColorectal can...
10.15.2026 Prnewswire.com and 32 sites
Actinium Pharmaceuticals to Showcase ATNM-400's First-in-Human Clinical Data in Prostate Cancer and Preclinical Results in Lung Cancer Supporting Pan-Tumor Potential Today at EANM 2026 PR Newswire NEW...
10.19.2026 Prnewswire.com and 10 sites
Cambridge City Council last week voted to grant permission for a second, identical application for the four-storey scheme at Christ’s College, drawn up by the 2021 Stirling Prize-winning practice. The...
10.14.2026 Architectsjournal.co.uk and 2 sites